{"id":9096,"date":"2019-10-21T10:30:00","date_gmt":"2019-10-21T08:30:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/"},"modified":"2019-10-21T10:30:00","modified_gmt":"2019-10-21T08:30:00","slug":"irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/","title":{"rendered":"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

IRLAB meddelade idag att Dr. Susanna Holm Waters, chef f\u00f6r biologi och biostatistik vid IRLAB, kommer att presentera en poster med titeln "Preclinical pharmacology of IRL752, a novel compound to treat postural instability and cognitive deficits in Parkinson\u2019s disease" p\u00e5 Society for Neuroscience (SfN) 2019 \u00e5rs \u2018Neuroscience conference\u2019. Konferensen kommer att \u00e4ga rum den 19-23 oktober p\u00e5 McCormick Place Convention Center i Chicago, USA.<\/strong><\/div>\n

Den internationella SfN Neuroscience-konferensen \u00e4r den st\u00f6rsta samlingen av forskare och sjukv\u00e5rdspersonal som arbetar inom neurovetenskap med m\u00e5let att fr\u00e4mja banbrytande uppt\u00e4ckter inom neurovetenskapen. Varje \u00e5r attraherar konferensen 30 000 ledande neurovetenskapsm\u00e4n som delar sina senaste forskningsresultat och presenterar ny vetenskap bland branschkollegor. 2019 \u00e5rs konferens markerar ocks\u00e5 50-\u00e5rsjubileet f\u00f6r Society for Neuroscience.<\/span><\/p>\n

Clas Sonesson, forskningschef p\u00e5 IRLAB, kommenterade \u201dSfN Neuroscience-konferensen \u00e4r den mest betydelsefulla konferensen f\u00f6r forskare inom neurovetenskap \u00f6ver hela v\u00e4rlden. Det \u00e4r viktigt f\u00f6r IRLAB att vara n\u00e4rvarande vid dessa typer av kongresser f\u00f6r att kunna visa och diskutera v\u00e5r forskning i det medicinska samfundet. Deltagarna best\u00e5r inte bara av ledande experter och forskare p\u00e5 omr\u00e5det utan ocks\u00e5 n\u00e5gra av v\u00e4rldens viktigaste l\u00e4kemedelsf\u00f6retag.\u201d<\/span><\/p>\n

Hitta posterpresentationen p\u00e5 kongressen:<\/span><\/p>\n

Presentationstid: onsdag 23 oktober kl 09:00 \u2013 10: 00<\/span><\/p>\n

Presentationsnummer: 653.18<\/span><\/p>\n

Titel: Preclinical pharmacology of IRL752, a novel compound to treat postural instability and cognitive deficits in Parkinson\u2019s disease<\/span><\/p>\n

Session titel: Genetic models of Parkinson\u2019s disease<\/span><\/p>\n

L\u00e4nk: <\/span>http:\/\/bit.ly\/irlab_poster_sfn<\/span>\u00a0<\/a><\/p>\n

\n

F\u00f6r vidare information<\/strong><\/p>\n

Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
Tel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0
E-post: nicholas.waters@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

IRLAB \u00e4r ett svenskt biotechbolag fokuserat p\u00e5 Parkinsons sjukdom. Bolagets kliniska Fas II-kandidater, IRL752 och IRL790, \u00e4mnar behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom: ofrivilliga r\u00f6relser (LIDs), psykos och demens. Genom den propriet\u00e4ra forskningsplattformen ISP (Integrative Screening Process) uppt\u00e4cker och utvecklar IRLAB l\u00e4kemedelskandidater f\u00f6r sjukdomar relaterade till det centrala nervsystemet (CNS) d\u00e4r stora v\u00e4xande medicinska behov f\u00f6religger. F\u00f6rutom de kliniska kandidaterna har ISP-plattformen dessutom genererat flera CNS-program som nu \u00e4r i preklinisk fas. IRLAB:s Certified Adviser p\u00e5 Nasdaq First North \u00e4r FNCA Sweden AB, info@fnca.se, 08-528 00 399. Mer information p\u00e5 www.irlab.se<\/a>.<\/p>\n<\/div>\n

[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"

IRLAB meddelade idag att Dr. Susanna Holm Waters, chef f\u00f6r biologi och biostatistik vid IRLAB, kommer att presentera en poster med titeln ”Preclinical pharmacology of IRL752, a novel compound to treat postural instability and cognitive deficits in Parkinson’s disease” p\u00e5 Society for Neuroscience (SfN) 2019 \u00e5rs ’Neuroscience conference’. Konferensen kommer att \u00e4ga rum den 19-23 oktober p\u00e5 McCormick Place Convention Center i Chicago, USA.<\/p>\n","protected":false},"template":"","class_list":["post-9096","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB meddelade idag att Dr. Susanna Holm Waters, chef f\u00f6r biologi och biostatistik vid IRLAB, kommer att presentera en poster med titeln "Preclinical pharmacology of IRL752, a novel compound to treat postural instability and cognitive deficits in Parkinson's disease" p\u00e5 Society for Neuroscience (SfN) 2019 \u00e5rs 'Neuroscience conference'. Konferensen kommer att \u00e4ga rum den 19-23 oktober p\u00e5 McCormick Place Convention Center i Chicago, USA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/\",\"name\":\"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2019-10-21T08:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference - IRLAB","og_description":"IRLAB meddelade idag att Dr. Susanna Holm Waters, chef f\u00f6r biologi och biostatistik vid IRLAB, kommer att presentera en poster med titeln \"Preclinical pharmacology of IRL752, a novel compound to treat postural instability and cognitive deficits in Parkinson's disease\" p\u00e5 Society for Neuroscience (SfN) 2019 \u00e5rs 'Neuroscience conference'. Konferensen kommer att \u00e4ga rum den 19-23 oktober p\u00e5 McCormick Place Convention Center i Chicago, USA.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/","name":"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2019-10-21T08:30:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-society-for-neuroscience-2019-ars-neuroscience-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar vid Society for Neuroscience 2019 \u00e5rs Neuroscience conference"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}